+ Filter
Loading...
HLA-C
Anti-HLA-C Recombinant Antibody Products
- PE-HLA-E/Human HLA-C (VMAPRTLFL) MHC Tetramer (MHC-LC1400)
-
- Class: Class I
- Antigen: HLA-C
- Antigen Species: Human
- Peptide: VMAPRTLFL
- Conjugate: PE
Compare
- PE-HLA-E/Human HLA-C (VMAPRALLL) MHC Tetramer (MHC-LC1403)
-
- Class: Class I
- Antigen: HLA-C
- Antigen Species: Human
- Peptide: VMAPRALLL
- Conjugate: PE
Compare
- APC-HLA-E/Human HLA-C (VMAPRTLFL) MHC Tetramer (MHC-LC1401)
-
- Class: Class I
- Antigen: HLA-C
- Antigen Species: Human
- Peptide: VMAPRTLFL
- Conjugate: APC
Compare
- APC-HLA-E/Human HLA-C (VMAPRALLL) MHC Tetramer (MHC-LC1404)
-
- Class: Class I
- Antigen: HLA-C
- Antigen Species: Human
- Peptide: VMAPRALLL
- Conjugate: APC
Compare
- BV421-HLA-E/Human HLA-C (VMAPRTLFL) MHC Tetramer (MHC-LC1402)
-
- Class: Class I
- Antigen: HLA-C
- Antigen Species: Human
- Peptide: VMAPRTLFL
- Conjugate: BV421
Compare
- PE-B*07:02/Human HLA-C (APRALLLLL) MHC Tetramer (MHC-LC4453)
-
- Class: Class I
- Antigen: HLA-C
- Antigen Species: Human
- Peptide: APRALLLLL
- Conjugate: PE
Compare
- BV421-HLA-E/Human HLA-C (VMAPRALLL) MHC Tetramer (MHC-LC1405)
-
- Class: Class I
- Antigen: HLA-C
- Antigen Species: Human
- Peptide: VMAPRALLL
- Conjugate: BV421
Compare
- PE-A*03:01/Human HLA-C (RVMAPRALL) MHC Tetramer (MHC-LC2356)
-
- Class: Class I
- Antigen: HLA-C
- Antigen Species: Human
- Peptide: RVMAPRALL
- Conjugate: PE
Compare
- PE-B*07:02/Human HLA-C (RVMAPRALL) MHC Tetramer (MHC-LC2357)
-
- Class: Class I
- Antigen: HLA-C
- Antigen Species: Human
- Peptide: RVMAPRALL
- Conjugate: PE
Compare
-
- Class: Class II
- Antigen: HLA-C
- Antigen Species: Human
- Peptide: GPEYWDRETQKYKRQAQ
- Conjugate: PE
Compare
More Infomation
Can't find the products you're looking for? Try to filter in the left sidebar.Filter By Tag
More Infomation
Our customer service representatives are available 24 hours a day, from Monday to Sunday. Contact Us
For Research Use Only. Not For Clinical Use.
HLA-C belongs to the HLA class I heavy chain paralogues. This class I molecule is a heterodimer consisting of a heavy chain and a light chain (beta-2 microglobulin). The heavy chain is anchored in the membrane. Class I molecules play a central role in the immune system by presenting peptides derived from endoplasmic reticulum lumen. They are expressed in nearly all cells. The heavy chain is approximately 45 kDa and its gene contains 8 exons. Exon one encodes the leader peptide, exons 2 and 3 encode the alpha1 and alpha2 domain, which both bind the peptide, exon 4 encodes the alpha3 domain, exon 5 encodes the transmembrane region, and exons 6 and 7 encode the cytoplasmic tail. Polymorphisms within exon 2 and exon 3 are responsible for the peptide binding specificity of each class one molecule. Typing for these polymorphisms is routinely done for bone marrow and kidney transplantation. Over one hundred HLA-C alleles have been described [provided by RefSeq, Jul 2008]
Protein class
Disease related genes, Human disease related genes, Plasma proteins
Predicted location
Intracellular, Membrane (different isoforms)
Single cell type specificity
Cell type enhanced (NK-cells, Proximal enterocytes)
Immune cell specificity
Low immune cell specificity
Cell line specificity
Cell line enhanced (A-431, EFO-21, RPTEC TERT1, U-266/70, U-266/84, U-698)
Interaction
Heterotrimer that consists of an alpha chain HLA-C, a beta chain B2M and a peptide (peptide-HLA-C-B2M) (PubMed:28649982, PubMed:10850706, PubMed:24990997). Early in biogenesis, HLA-C-B2M dimer interacts with the components of the peptide-loading complex composed of TAPBP, TAP1-TAP2, TAPBPL, PDIA3/ERP57 and CALR (PubMed:18420581). Interacts with TAP1-TAP2 transporter via TAPBP; this interaction is obligatory for the loading of peptide epitopes delivered to the endoplasmic reticulum (ER) by TAP1-TAP2 transporter (By similarity). Being very selective in the peptide binding, forms a stable interaction with TAP1-TAP2, often leading to the accumulation of free heavy chains in the ER (PubMed:18420581). Only optimally assembled peptide-HLA-C-B2M trimer translocates to the surface of antigen-presenting cells, where it interacts with TCR and CD8 coreceptor on the surface of T cells. HLA-C (via polymorphic alpha-1 and alpha-2 domains) interacts with antigen-specific TCR (via CDR3 domains) (By similarity). One HLA-C molecule (mainly via nonpolymorphic alpha-3 domain) interacts with one CD8A homodimer (via CDR-like loop); this interaction insures peptide-HLA-C-B2M recognition by CD8-positive T cells only (By similarity). The peptide-HLA-C-B2M complex also interacts with KIRs. HLA-C type 1 (C1, with Asn104), including HLA-C*02, C*04, C*05, C*06 and C*15, interact with KIR2DL1 and KIR2DS1, and HLA-C type 2 (C2, with Lys104), including HLA-C*01, C*03, C*07 and C*08, interact with KIR2DL2 and KIR2DL3 (PubMed:20972337, PubMed:24091323, PubMed:16141329, PubMed:20439706, PubMed:11323700, PubMed:10850706). (Microbial infection) Interacts with HTLV-1 p12I accessory protein.
More Types Infomation